medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2015, Número 4

<< Anterior Siguiente >>

Ann Hepatol 2015; 14 (4)


Giant hepatocellular adenoma in a previously obese thirteen-year-old boy

Rosencrantz RA, Youmin W, Pierre-Yves S , Yusuf Y

Idioma: Ingles.
Referencias bibliográficas: 22
Paginas: 559-563
Archivo PDF: 219.54 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Stocker JT. Hepatic Tumors in Children. Clin Liver Dis 2001; 5: 259-81.

  2. Applegate K, Ghei M, Perez-Atayde A. Prenatal detection of a solitary liver adenoma. Pediatr Radiol 1999; 29: 92-4.

  3. Gorayski P, Thompson CH, Subhash HS, Thomas AC. Hepatocellular carcinoma associated with recreational anabolic steroid use. Br J Sports Med 2008; 42: 74-5.

  4. Rooks JB, Ory HW, Ishak KG. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 1979; 242: 644-8.

  5. Labrune P, Trioche P, Duvaltier I, Chevalier P, Odievre M. Hepatocellular Adenomas in Glycogen Storage Disease Type 1 and 3: A Series of 43 Patients and Review of the Literature. J Pediatr Gastroenterol Nutr 1997; 24: 276-9.

  6. Paradis V, Champault A, Ronot M, Deschamps L, Valla DC, Vidaud D, Vilgrain V, et al. Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology 2007; 46: 140-6.

  7. Bunchorntavakul C, Bahirwani R,Drazek D, Soulen MC, Siegelman ES, Furth EE, Olthoff K, et al. Clinical features and natural history of hepatocellular adenomas: the impact of obesity. Aliment Pharmacol Ther 2011; 34: 664-74.

  8. Franchi-Abella S, Branchereau S. Benign Hepatocellular Tumors in Children: Focal Nodular Hyperplasia and Hepatocellular Adenoma. [published online ahead of print March 11 2013]. Int J Hepatol 2013. doi: 10.1155/2013/215064.

  9. Leese T, Farges O, Bismuth H. Liver Cell Adenomas: A 12- Year Surgical Experience From a Specialist Hepato-Biliary Unit. Ann Surgery 1988; 208: 558-64.

  10. Nichols F, van Heerden J, Weiland L. Benign Liver Tumors. Surg Clin of North Am 1989; 69: 297-314.

  11. Labrune P, Trioche P, Duvaltier I, Chevalier P, Odievre M. Hepatocellular Adenomas in Glycogen Storage Disease Type I and III: A Series of 43 Patients and Review of The Literature. J Pediatr Gastroenterol Nutr 1997; 24: 276-9.

  12. Wang DQ, Fiske LM, Carreras CT, Weinstein DA. Natural History of Hepatocellular Adenoma Formation in Glycogen Storage Disease Type 1. J Pediatr 2011; 159: 442-6.

  13. Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, Laurent C, et al. Hepatocellular Adenoma Management and Phenotypic Classification: the Bordeaux Experience. Hepatology 2009; 50: 481-9.

  14. Stoot JHMB, Coelen RJS, de Jong MC, de Jong CH. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systemic review including more than 1600 adenoma cases. HPB (Oxford) 2010; 12: 509-22.

  15. Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, Bedossa P, et al. A Single-Center Surgical Experience of 122 Patients with Single and Multiple Hepatocellular Adenomas. Gastroenterology 2009; 137: 1698-705.

  16. Fritz V, Fajas L. Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene 2010; 29: 4369-77.

  17. Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B, Gambarini S. Hepatocellular Adenoma and Focal Nodular Hyperplasia: Value of Gadoxetic Acid-enhanced MR Imaging in Differential Diagnosis. Radiology 2012; 262: 520-9.

  18. Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular Adenomas: Magnetic Resonance Imaging Features As a Function of Molecular Pathological Classification. Hepatology 2008; 48: 808-18.

  19. Van Aalten SM, de Man RA, IJzermans JN, Turkivatan T. Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg 2012; 99: 911-16.

  20. Nault JC, Bioulac-Sage P, Zucman-Rossi J. Hepatocellular Benign Tumors-From Molecular Classification to Personalized Clinical Care. Gastroenterology 2013; 144: 888-902.

  21. Marrero JA, Ahn J, Reddy KR. ACG Clinical Guideline: The Diagnosis and Management of Focal Liver Lesions. Am J Gastroenterol 2014; 109: 1328-47.

  22. Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, Fava J, et al. Randomized Control Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis (NASH). Hepatology 2010; 51: 121-9.




2020     |     www.medigraphic.com